相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?
James M. Clay et al.
LANCET PUBLIC HEALTH (2020)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
Ben Sessa et al.
FRONTIERS IN PSYCHIATRY (2019)
Psychiatric comorbidities in alcohol use disorder
Alvaro Castillo-Carniglia et al.
LANCET PSYCHIATRY (2019)
Why MDMA therapy for alcohol use disorder? And why now?
Ben Sessa
NEUROPHARMACOLOGY (2018)
The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity
Robin L. Carhart-Harris et al.
BIOLOGICAL PSYCHIATRY (2015)
Can psychedelic compounds play a part in drug dependence therapy?
Ben Sessa et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories
R. L. Carhart-Harris et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
A. R. Lingford-Hughes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor
Karen L. Hanson et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)
Last Observation Carried Forward Versus Mixed Models in the Analysis of Psychiatric Clinical Trials
Robert M. Hamer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Brain serotonin transporter binding in former users of MDMA ('ecstasy')
Sudhakar Selvaraj et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Mindfulness-Based Therapies for Substance Use Disorders: Part 1
Marianne T. Marcus et al.
SUBSTANCE ABUSE (2009)
Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatil information unaffected
Kim P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2007)
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy
Harry R. Sumnall et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial
RF Anton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome
H Krampe et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
DS Harris et al.
PSYCHOPHARMACOLOGY (2002)
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
WR Miller et al.
ADDICTION (2002)
分享论文
